Acumen Pharmaceuticals, Inc.
ABOS
$2.72
$0.041.49%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -31.88% | -36.80% | -44.96% | -40.93% | -29.55% |
| Total Receivables | 72.70% | 125.08% | 430.19% | 274.07% | 43.75% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 597.90% | -30.46% | 77.89% | 17.03% | 6.32% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -28.65% | -29.11% | -29.68% | 77.69% | 197.32% |
| Total Current Assets | -31.44% | -36.35% | -44.40% | -39.43% | -27.70% |
|
|
|||||
| Total Current Assets | -31.44% | -36.35% | -44.40% | -39.43% | -27.70% |
| Net Property, Plant & Equipment | -28.32% | -25.19% | -22.09% | -20.64% | -32.60% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -61.33% | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 192.76% | 58.62% | -24.16% | -2.42% | -33.04% |
| Total Assets | -48.60% | -46.73% | -40.50% | -32.06% | -22.94% |
|
|
|||||
| Total Accounts Payable | -90.19% | -70.88% | -50.06% | -65.70% | 309.57% |
| Total Accrued Expenses | 90.06% | -0.37% | 106.35% | 269.51% | 105.40% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6,603.01% | 2,802.33% | 13.60% | 14.05% | -84.64% |
| Total Finance Division Other Current Liabilities | -21.74% | 75.12% | 8.05% | -13.10% | 8.49% |
| Total Other Current Liabilities | -21.74% | 75.12% | 8.05% | -13.10% | 8.49% |
| Total Current Liabilities | 8.69% | 10.25% | 61.78% | 127.99% | 112.84% |
|
|
|||||
| Total Current Liabilities | 8.69% | 10.25% | 61.78% | 127.99% | 112.84% |
| Long-Term Debt | -23.87% | -8.83% | 1.71% | -2.25% | -1.60% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -78.92% | -64.84% | -54.76% | -47.18% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -8.35% | -1.46% | 21.91% | 25.75% | 32.50% |
|
|
|||||
| Common Stock & APIC | 1.94% | 1.93% | 1.91% | 1.92% | 3.58% |
| Retained Earnings | -37.32% | -46.31% | -52.93% | -48.91% | -45.93% |
| Treasury Stock & Other | 272.92% | -78.96% | 114.02% | 110.42% | -115.38% |
| Total Common Equity | -61.26% | -57.10% | -52.01% | -40.65% | -31.90% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -61.26% | -57.10% | -52.01% | -40.65% | -31.90% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -61.26% | -57.10% | -52.01% | -40.65% | -31.90% |
|
|
|||||